Tumor lysis syndrome in a patient with merkel cell carcinoma and provoked pathologic sequence of acute kidney injury, reduced clearance of carboplatin and fatal pancytopenia

Onkologie

Volumn 34, Issue 11, 2011, Pages 626-629

  Grenader, Tal ^a   Shavit, Linda ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Acute kidney injury; AUC; Carboplatin; Chemotherapy; Merkel cell carcinoma; Pancytopenia; Tumor lysis syndrome

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CREATININE; ETOPOSIDE; LACTATE DEHYDROGENASE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CERVICAL LYMPH NODE; CHEMICAL ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DEATH; DISEASE SEVERITY; DRUG CLEARANCE; DYSPNEA; FEMALE; FEVER; GENERAL CONDITION DETERIORATION; HEMODIALYSIS; HUMAN; INGUINAL LYMPH NODE; KIDNEY CLEARANCE; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHADENOPATHY; LYMPHANGITIS; MERKEL CELL TUMOR; NOSE TUMOR; PANCYTOPENIA; PARAAORTIC LYMPH NODE; PHYSICAL EXAMINATION; PLASMA CONCENTRATION-TIME CURVE; PLEURA EFFUSION; SKIN METASTASIS; THROMBOCYTE TRANSFUSION; TUMOR LYSIS SYNDROME; URINE VOLUME; WEAKNESS;

ACUTE KIDNEY INJURY; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, MERKEL CELL; FATAL OUTCOME; FEMALE; HUMANS; PANCYTOPENIA; SKIN NEOPLASMS; TUMOR LYSIS SYNDROME;

EID: 81855224784     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000334196     Document Type: Article

References (14)

1. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE: Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010;37:20-27.
2. Agelli M, Clegg LX: Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003;49:832-841. (Pubitemid 37314870)
3. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG: Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300-2309. (Pubitemid 46218722)
4. Pumo V, Sciacca D, Malaguarnera M: Tumor lysis syndrome in elderly. Crit Rev Oncol Hematol 2007;64:31-42. (Pubitemid 47362734)
5. Gemici C: Tumour lysis syndrome in solid tumours. Clin Oncol (R Coll Radiol) 2006;18:773-780. (Pubitemid 44645411)
6. Jallad B, Hamdi T, Latta S, Alhosaini MN, Kheir F, Iroegbu N: Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature. Onkologie 2011;34:129-131.
7. Coiffier B: Acute tumor lysis syndrome-a rare complication in the treatment of solid tumors. Onkologie 2010;33:498-489.
8. Dirix LY, Prove A, Becquart D, Wouters E, Vermeulen P, Van Oosterom A: Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 1991;67:2207-2210.
9. OaposDwyer PJ, Stevenson JP, Johnson SW: Clinical pharmacokinetics and administration of established platinum drugs. Drugs 2000;59:19-27. (Pubitemid 30344988)
10. Fukuda M, Soda H, Soejima Y, Fukuda M, Kinoshita A, Takatani H, et al.: A phase I trial of carboplatin and etoposide for elderly (> or = 75 year-old) patients with small-cell lung cancer. Cancer Chemother Pharmacol 2006;58:601-606. (Pubitemid 44167385)
11. Okamoto H, Watanabe K, Nishiwaki Y, Mori K, Kurita Y, Hayashi I, et al.: Phase II study of area under the plasma-concentration versus-time curve-based carboplatin plus standard-dose intravenous etoposide in elderly patients with small-cell lung cancer. J Clin Oncol 1999;17:3540-3545. (Pubitemid 29517925)
12. Matsui K, Masuda N, Yana T, Takada Y, Kobayashi M, Nitta T, et al.: Carboplatin calculated with Chatelutaposs formula plus etoposide for elderly patients with small-cell lung cancer. Intern Med 2001;40:603-606. (Pubitemid 32799386)
13. Suzuki S, Koide M, Sakamoto S, Matsuo T: Pharmacokinetics of carboplatin and etoposide in a haemodialysis patient with Merkel-cell carcinoma. Nephrol Dial Transplant 1997;12:137-140. (Pubitemid 27046216)
14. Oguri T, Shimokata T, Inada M, Ito I, Ando Y, Sasaki Y, Hasegawa Y: Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis. Cancer Chemother Pharmacol 2010;66:813-817.